Episode 19: Hemostasis

So what's hemostasis? Hemostasis is the process that allows blood to remain fluid in the vasculature under normal conditions while also allowing the body to form a clot quickly when vascular injury occurs.

Under normal physiologic conditions, the body maintains a careful balance between forces that promote clotting and forces that prevent clotting.

And when a blood vessel is injured, the hemostatic system responds rapidly to limit blood loss and tissue damage.

However, when this balance becomes disrupted, patients can develop either hemorrhage or thrombosis.

At a big picture level, hemostasis can be divided into primary hemostasis, secondary hemostasis, regulation of clot formation, fibrinolysis, and the interaction between coagulation and inflammation, which includes immunothrombosis.

But when you're thinking about this clinically, Everything starts with primary hemostasis.

This is the first response to vascular injury, the immediate attempt to stop bleeding before the coagulation cascade even further ramps up.

Primary hemostasis involves the endothelium, platelets, and exposed subendothelial matrix after vascular injury.

Platelets are the main cellular effectors of primary hemostasis.

They're anuclear, discoid fragments derived from megakaryocytes.

Even though they don't have nuclei, they're still highly specialized cells with complex signaling systems, membrane receptors, integrins, and intracellular granules.

The platelet membrane contains an open canalicular system, which is a network of membrane-lined channels that allow substances to move into and out of the platelet, and I can't help but picture Luke Skywalker flying through the Death Star trenches here.

Platelets also contain a dense tubular system and specialized cytoplasmic granules, and the two major granule types are worth knowing.

So you have alpha granules, and those contain proteins involved in hemostasis, thrombosis, inflammation, angiogenesis, host defenses, and cell growth.

And then you have dense granules, which contain cations, polyphosphates, adenosine, nucleotides, serotonin, and histamine.

And a simple way to remember this is the alpha granules are protein heavy and build the clot environment, while dense granules are small molecule heavy and amplify platelet activation.

Another key platelet concept is the integrin receptor family.

These receptors mediate cell-to-cell and cell-to-matrix interactions.

And the most abundant platelet integrin is alpha-2b-beta-3.

This receptor binds fibrinogen and also von Willebrand factor to a lesser extent.

allowing platelets to link to one another and form aggregates.

This is a very high yield fact.

So alpha-2b-beta-3 binds fibrinogen and allows these platelets to link to one another and form aggregates.

Platelets also contain important agonist receptors, including thrombin receptors called protease-activated receptors, adenosine diphosphate receptors called P2Y1 and P2Y12, thromboxane receptors, and prostacyclin and prostaglandin receptors.

So now that we understand the structure, let's talk about how platelets actually work in real time.

So what's hemostasis? Hemostasis is the process that allows blood to remain fluid in the vasculature under normal conditions while also allowing the body to form a clot quickly when vascular injury occurs.

Under normal physiologic conditions, the body maintains a careful balance between forces that promote clotting and forces that prevent clotting.

And when a blood vessel is injured, the hemostatic system responds rapidly to limit blood loss and tissue damage.

However, when this balance becomes disrupted, patients can develop either hemorrhage or thrombosis.

At a big picture level, hemostasis can be divided into primary hemostasis, secondary hemostasis, regulation of clot formation, fibrinolysis, and the interaction between coagulation and inflammation, which includes immunothrombosis.

But when you're thinking about this clinically, Everything starts with primary hemostasis.

This is the first response to vascular injury, the immediate attempt to stop bleeding before the coagulation cascade even further ramps up.

Primary hemostasis involves the endothelium, platelets, and exposed subendothelial matrix after vascular injury.

Platelets are the main cellular effectors of primary hemostasis.

They're anuclear, discoid fragments derived from megakaryocytes.

Even though they don't have nuclei, they're still highly specialized cells with complex signaling systems, membrane receptors, integrins, and intracellular granules.

The platelet membrane contains an open canalicular system, which is a network of membrane-lined channels that allow substances to move into and out of the platelet, and I can't help but picture Luke Skywalker flying through the Death Star trenches here.

Platelets also contain a dense tubular system and specialized cytoplasmic granules, and the two major granule types are worth knowing.

So you have alpha granules, and those contain proteins involved in hemostasis, thrombosis, inflammation, angiogenesis, host defenses, and cell growth.

And then you have dense granules, which contain cations, polyphosphates, adenosine, nucleotides, serotonin, and histamine.

And a simple way to remember this is the alpha granules are protein heavy and build the clot environment, while dense granules are small molecule heavy and amplify platelet activation.

Another key platelet concept is the integrin receptor family.

These receptors mediate cell-to-cell and cell-to-matrix interactions.

And the most abundant platelet integrin is alpha-2b-beta-3.

This receptor binds fibrinogen and also von Willebrand factor to a lesser extent.

allowing platelets to link to one another and form aggregates.

This is a very high yield fact.

So alpha-2b-beta-3 binds fibrinogen and allows these platelets to link to one another and form aggregates.

Platelets also contain important agonist receptors, including thrombin receptors called protease-activated receptors, adenosine diphosphate receptors called P2Y1 and P2Y12, thromboxane receptors, and prostacyclin and prostaglandin receptors.

So now that we understand the structure, let's talk about how platelets actually work in real time.